Cerebral Palsy: From Diagnosis to Management
Cerebral palsy (CP) is a group of permanent disorders affecting movement and posture caused by non-progressive disturbances in the developing fetal or infant brain, requiring early diagnosis and prompt intervention to optimize neuroplasticity, prevent secondary complications, and enhance quality of life. 1, 2
Definition and Epidemiology
- CP is the most common physical disability in childhood, with a prevalence of 2.1 cases per 1000 live births in high-income countries 2
- The prevalence appears to be declining in Australia and Europe but remains higher in low to middle-income countries due to greater infectious disease burden and differences in prenatal and perinatal care 2
- CP encompasses multiple etiologies resulting in brain injury affecting movement, posture, and balance 3
Etiology and Risk Factors
- Genetic factors: Recent evidence suggests genetic components in approximately 31.1% of CP cases, with higher diagnostic yield in pediatric populations (34.8%) than adult populations (26.9%) 1
- Maternal conditions: Thyroid disease, preeclampsia, infections 2
- Pregnancy complications: Intrauterine growth restriction, multiple gestation 2
- Preconception risks: History of stillbirths, miscarriages, low socioeconomic status, assisted reproduction 2
- Birth complications: Contrary to common belief, birth asphyxia accounts for less than 10% of CP cases 1
- Prematurity and low birth weight are significant risk factors 4
Clinical Classification
- Spasticity (85%-91%): Most common motor type, characterized by increased muscle tone 1, 2
- Dyskinesia (4%-7%): Includes dystonia and athetosis 1, 2
- Ataxia (4%-6%): Characterized by problems with coordination and balance 1, 2
- Hypotonia (2%): Not classified in all countries 1, 2
Topographical Classification
- Unilateral (hemiplegia): Affects one side of the body (38%) 1, 2
- Bilateral diplegia: Lower limbs affected more than upper limbs (37%) 1, 2
- Quadriplegia: All four limbs and trunk affected (24%) 1, 2
Diagnosis
Early Diagnostic Tools
Before 5 months' corrected age:
After 5 months' corrected age:
Neuroimaging Findings
- White matter injury (cystic periventricular leukomalacia or periventricular hemorrhagic infarctions) (56%) 2
- Cortical and deep gray matter lesions (18%) 2
- Brain maldevelopments (9%) 2
Common Comorbidities
- Chronic pain (75%) 1, 2
- Epilepsy (35%) 1, 2
- Intellectual disability (49%) 1, 2
- Musculoskeletal problems (e.g., hip displacement) (28%) 1, 2
- Behavioral disorders (26%) 1, 2
- Sleep disorders (23%) 1, 2
- Visual impairment (11%) 1, 2
- Hearing impairment (4%) 1, 2
Management Approach
Early Intervention
- Early diagnosis and prompt referral to CP-specific intervention is essential to optimize infant motor and cognitive plasticity, prevent secondary complications, and enhance caregiver well-being 1, 2
- Intervention should begin as soon as CP is suspected rather than waiting for definitive diagnosis 2
- Early intervention maximizes neuroplasticity and minimizes deleterious modifications to muscle and bone growth 1
Motor Interventions
- For unilateral CP (hemiplegia): Constraint-induced movement therapy (CIMT) or bimanual therapy 1, 2
- For bilateral CP (diplegia): Learning Games Curriculum 1
- For all subtypes: Goals-Activity-Motor Enrichment (GAME) 1
- Physical and occupational therapy using child-initiated movement, task-specific practice, and environmental adaptations 1
Spasticity Management
- Intramuscular onabotulinumtoxinA injections 5, 3
- Oral muscle relaxants 5, 3
- Intrathecal baclofen 5, 3
- Selective dorsal rhizotomy 5, 3
- Regular surveillance and intervention for children with bilateral CP to reduce rates of hip displacement, contracture, and scoliosis 1
Communication Interventions
- Speech language pathology interventions to foster parent-infant transactions 1
- Augmentative communication when speech is not possible or inadequate 1
Prognosis
- In high-income countries:
Emerging Treatments
- Regenerative agents to induce brain repair are being studied:
- Exome sequencing is recommended for diagnostic evaluation of individuals with CP, similar to other neurodevelopmental disorders 1